[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","l54eabgw7hayagbv9ia11peu9","revision",2,"title","Fresenius Medical Care AG 发布 2026 年 10 月 7 日新闻稿","originalTitle","6-K - Fresenius Medical Care AG (0001333141) (Filer)","summary","Fresenius Medical Care AG 发布 2026 年 10 月 7 日新闻稿。该文件为公司向 SEC 提交的 6-K 报告的一部分。报告包含公司财务与合规相关信息。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":57,"_91":92,"_93":94},"links",{"_82":83,"_63":84},"publishedAt","2026-10-07T18:19:54.000Z","discoveredAt","2026-10-07T18:22:23.822Z","timelineAt","category","tip","tags",[80,81],"stockSymbols",[],"score",17,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fuIvN3Zd10LA",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","32edcc3b-f1df-43ca-92e0-fa32c15000a8","Fresenius Medical Care AG 提交 6-K 报告",{"_72":73,"_15":74},"zh","

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of October 2026

Commission file number: 001-32749

FRESENIUS MEDICAL\nCARE AG

(Translation of registrant's name into English)

Else-Kröner-Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

Indicate by check mark whether\nthe registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F\nx Form 40-F\n¨

EXHIBITS

The following exhibits are being furnished with\nthis Report:

\n\n

Exhibit 99.1

Press Release issued on October 7, 2026.

SIGNATURES

Pursuant to the requirements\nof the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto\nduly authorized.

DATE: October 7, 2026 

\n \n \n \n \n \n \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n

	Fresenius Medical Care AG

	By:	/s/ Martin Fischer
	Name:	Martin Fischer
	Title:	Chief Financial Officer and member of the Management Board

	By:	/s/ Dr. Jörg Häring
	Name:	Dr. Jörg Häring
	Title:	Management Board member responsible for Legal, Compliance and Human Resources

","zhKind","complete","政策与监管","财报","aihot","/items/l54eabgw7hayagbv9ia11peu9","https://www.sec.gov/Archives/edgar/data/1333141/000110465926114302/0001104659-26-114302-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1791590400&sig=4febbd6b569486c4","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1791590400&sig=b2d04423d06d263c 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1791590400&sig=6668906c0ecbb2a7 96w","changelogVersion","2026-10-01T08:00"]